{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:31:09Z","timestamp":1776781869758,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,6,17]],"date-time":"2015-06-17T00:00:00Z","timestamp":1434499200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11883-015-0525-6","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:57:46Z","timestamp":1434416266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PFO Closure for Cryptogenic Stroke"],"prefix":"10.1007","volume":"17","author":[{"given":"Sabreena J.","family":"Gillow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,17]]},"reference":[{"key":"525_CR1","first-page":"11","volume":"66","author":"H Lippman","year":"1993","unstructured":"Lippman H, Rafferty T. Patent foramen ovale and paradoxical embolization: a historical perspective. Yale J of Biol and Med. 1993;66:11\u20137.","journal-title":"Yale J of Biol and Med"},{"issue":"11","key":"525_CR2","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/01.CIR.91.11.2785","volume":"91","author":"A Mugge","year":"1995","unstructured":"Mugge A, Daniel WG, Angermann C, Spes C, et al. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation. 1995;91(11):2785\u201392.","journal-title":"Circulation"},{"issue":"1","key":"525_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","volume":"59","author":"PT Hagen","year":"1984","unstructured":"Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17\u201320.","journal-title":"Mayo Clin Proc"},{"key":"525_CR4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","volume":"112","author":"S Homma","year":"2005","unstructured":"Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation. 2005;112:1063\u2013107.","journal-title":"Circulation"},{"issue":"1","key":"525_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/01.STR.24.1.31","volume":"24","author":"D Ranoux","year":"1993","unstructured":"Ranoux D, Cohen A, Cabanes L, Amarenco P, et al. Patent foramen ovale: is stroke due to paradoxical embolism? Stroke. 1993;24(1):31\u20134.","journal-title":"Stroke"},{"issue":"3","key":"525_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12998\/wjcc.v1.i3.108","volume":"1","author":"L Cormack","year":"2013","unstructured":"Cormack L, Murchison JT. Paradoxical embolus straddling patent foramen ovale demonstrated by computed tomographic pulmonary angiography. World J Clin Cases. 2013;1(3):108\u201310.","journal-title":"World J Clin Cases"},{"issue":"24","key":"525_CR7","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJMoa011503","volume":"345","author":"J Mas","year":"2001","unstructured":"Mas J, Arquizan C, Lamy C, Zuber M. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345(24):1740\u20136.","journal-title":"N Engl J Med"},{"issue":"3-4","key":"525_CR8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000375152","volume":"34","author":"D Consoli","year":"2015","unstructured":"Consoli D, Paciaroni M, Galati F, Aguggia M, et al. Prevalence of patent foramen ovale in ischaemic stroke in Italy: results of SISIFO study. Cerebrovasc Dis. 2015;34(3-4):162\u20139.","journal-title":"Cerebrovasc Dis"},{"issue":"14","key":"525_CR9","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1056\/NEJMc073549","volume":"358","author":"MA Meyer","year":"2008","unstructured":"Meyer MA. Patent foramen ovale and cryptogenic stroke. N Engl J Med. 2008;358(14):1518.","journal-title":"N Engl J Med"},{"issue":"12","key":"525_CR10","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","volume":"32","author":"PL Kolominsky-Rabas","year":"2001","unstructured":"Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, et al. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke J Cerebral Circ. 2001;32(12):2735\u201340.","journal-title":"Stroke J Cerebral Circ"},{"issue":"4","key":"525_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/ana.410250410","volume":"25","author":"RL Sacco","year":"1989","unstructured":"Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989;25(4):382\u201390.","journal-title":"Ann Neurol"},{"issue":"4","key":"525_CR12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/STROKEAHA.108.529883","volume":"40","author":"J Putaala","year":"2009","unstructured":"Putaala J, Metso AJ, Metso TM, Konkola N, et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195\u2013203.","journal-title":"Stroke"},{"issue":"18","key":"525_CR13","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198805053181802","volume":"318","author":"P Lechat","year":"1988","unstructured":"Lechat P, Mas JL, Lascault G, Loron P, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318(18):1148\u201352.","journal-title":"N Engl J Med"},{"issue":"8601","key":"525_CR14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(88)92944-3","volume":"2","author":"MW Webster","year":"1988","unstructured":"Webster MW, Chancellor AM, Smith HJ, Swift DL, et al. Patent foramen ovale in young stroke patients. Lancet. 1988;2(8601):11\u20132.","journal-title":"Lancet"},{"key":"525_CR15","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1056\/NEJMoa071422","volume":"357","author":"M Handke","year":"2007","unstructured":"Handke M, Harloff A, Olschewski M, Hetzel A, et al. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med. 2007;357:2262\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"525_CR16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4065\/81.5.602","volume":"81","author":"GW Petty","year":"2006","unstructured":"Petty GW, Khandheria BK, Meissner I, Whisnant JP, et al. Population-based study of the relationship between patent foramen ovlae and cerebrovascular ischemic events. Mayo Clin Proc. 2006;81(5):602\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"525_CR17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jacc.2005.10.044","volume":"47","author":"I Meissner","year":"2006","unstructured":"Meissner I, Khandheria BK, Heit JA, Petty GW, et al. Patent foramen ovale: innocent or guilty? Evidence from a prospective population-based study. J Am Coll Cardiol. 2006;47(2):440\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"525_CR18","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacc.2006.08.063","volume":"49","author":"MR Tullio Di","year":"2007","unstructured":"Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49(7):797\u2013802.","journal-title":"J Am Coll Cardiol"},{"key":"525_CR19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.0b013e3181aa2a19","volume":"73","author":"MA Almekhlafi","year":"2009","unstructured":"Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, et al. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology. 2009;73:89\u201397.","journal-title":"Neurology"},{"issue":"12","key":"525_CR20","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.STR.24.12.1865","volume":"24","author":"L Cabenes","year":"1993","unstructured":"Cabenes L, Mas JL, Cohen A, Amarenco P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55\u00a0years of age. A study using transesophageal echocardiography. Stroke. 1993;24(12):1865\u201373.","journal-title":"Stroke"},{"issue":"7","key":"525_CR21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00007611-200194070-00016","volume":"94","author":"MA Orgera","year":"2001","unstructured":"Orgera MA, O\u2019Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J. 2001;94(7):699\u2013703.","journal-title":"South Med J"},{"key":"525_CR22","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.CIR.0000017498.88393.44","volume":"105","author":"S Homma","year":"2002","unstructured":"Homma S, Sacco RL, Di Tullio MR, Sciacca RR, et al. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105:2625\u201331.","journal-title":"Circulation"},{"issue":"20","key":"525_CR23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"JP Mohr","year":"2001","unstructured":"Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001;345(20):1444\u201351.","journal-title":"N Engl J Med"},{"issue":"1","key":"525_CR24","first-page":"57","volume":"15","author":"B Cujec","year":"1999","unstructured":"Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol. 1999;15(1):57\u201364.","journal-title":"Can J Cardiol"},{"issue":"10","key":"525_CR25","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/01.STR.31.10.2407","volume":"31","author":"S Castro De","year":"2000","unstructured":"De Castro S, Cartoni D, Fiorelli M, Rasura M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31(10):2407\u201313.","journal-title":"Stroke"},{"key":"525_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jnnp.72.3.347","volume":"72","author":"K Nedeltchev","year":"2001","unstructured":"Nedeltchev K, Arnold M, Wahl A, Sturzeneggar M, et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry. 2001;72:347\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"525_CR27","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.3949\/ccjm.74.Suppl_1.S118","volume":"74","author":"AJ Furlan","year":"2007","unstructured":"Furlan AJ. Patent foramen ovale and stroke: to close or not to close? Cleve Clin J of Med. 2007;74(1):S118\u2013120.","journal-title":"Cleve Clin J of Med"},{"issue":"5","key":"525_CR28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/WNL.47.5.1162","volume":"47","author":"G Devuyst","year":"1996","unstructured":"Devuyst G, Bogousslavsky J, Ruchat P, Jeanrenaud X. Prognosis after stroke followed by surgical closure of patent foramen ovale: a prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology. 1996;47(5):1162\u20136.","journal-title":"Neurology"},{"issue":"10 suppl","key":"525_CR29","first-page":"II171","volume":"100","author":"JA Dearani","year":"1999","unstructured":"Dearani JA, Ugurlu BS. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999;100(10 suppl):II171\u20135.","journal-title":"Circulation"},{"issue":"6","key":"525_CR30","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1161\/01.CIR.86.6.1902","volume":"86","author":"ND Bridges","year":"1999","unstructured":"Bridges ND, Hellenbrand W, Latson L, Filiano J, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1999;86(6):1902\u20138.","journal-title":"Circulation"},{"issue":"9","key":"525_CR31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-139-9-200311040-00010","volume":"139","author":"P Khairy","year":"2003","unstructured":"Khairy P, O\u2019Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139(9):753\u201360.","journal-title":"Ann Intern Med"},{"issue":"4","key":"525_CR32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2004.05.044","volume":"44","author":"S Windecker","year":"2004","unstructured":"Windecker S, Wahl A, Nedeltchev K, Arnold M, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44(4):750\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"525_CR33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/ccd.20868","volume":"68","author":"BV Thanopoulos","year":"2006","unstructured":"Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv. 2006;68(5):741\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"525_CR34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1017\/S0317167100005825","volume":"34","author":"L Casaubon","year":"2007","unstructured":"Casaubon L, McLaughlin P, Webb G, Yeo E, et al. Recurrent stroke\/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci. 2007;34(1):74\u201380.","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"525_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S0317167100004674","volume":"33","author":"JU Harrer","year":"2006","unstructured":"Harrer JU, Wessels T, Franke A, Lucas S. Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neurol Sci. 2006;33(1):39\u201347.","journal-title":"Can J Neurol Sci"},{"issue":"9","key":"525_CR36","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/01.CIR.0000027819.19722.EE","volume":"106","author":"F Martin","year":"2002","unstructured":"Martin F, Sanchez PL, Doherty E, Colon-Hernandez PJ, et al. Percutaneous transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Circulation. 2002;106(9):1121\u20136.","journal-title":"Circulation"},{"issue":"7","key":"525_CR37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.57.7.1330","volume":"57","author":"A Wahl","year":"2001","unstructured":"Wahl A, Meier B, Haxel B, Nedeltchev K, et al. Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology. 2001;57(7):1330\u20132.","journal-title":"Neurology"},{"issue":"8","key":"525_CR38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.CIR.101.8.893","volume":"101","author":"S Windecker","year":"2000","unstructured":"Windecker S, Wahl A, Chatterjee T, Garachemani A, et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism:long-term risk of recurrent thromboembolic events. Circulation. 2000;101(8):893\u20138.","journal-title":"Circulation"},{"issue":"3","key":"525_CR39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jacc.2004.10.043","volume":"45","author":"A Wahl","year":"2005","unstructured":"Wahl A, Krumsdorf U, Meier B, Sievert H, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol. 2005;45(3):377\u201380.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"525_CR40","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4244\/EIJV9I12A239","volume":"9","author":"V Rudolph","year":"2014","unstructured":"Rudolph V, Augustin J, Hofmann T, Hamm CW, et al. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale. EuroIntervention. 2014;9(12):1418\u201322.","journal-title":"EuroIntervention"},{"issue":"6","key":"525_CR41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.euje.2005.09.007","volume":"6","author":"M Schwerzmann","year":"2005","unstructured":"Schwerzmann M, Salehian O. Hazards of percutaneous closure. Eur J Echocardiogr. 2005;6(6):393\u20135.","journal-title":"Eur J Echocardiogr"},{"issue":"7","key":"525_CR42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/hrt.2007.132662","volume":"94","author":"SP Schoen","year":"2008","unstructured":"Schoen SP, Boscheri A, Lange SA, Braun MU, et al. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale. Heart. 2008;94(7):844\u20137.","journal-title":"Heart"},{"issue":"1","key":"525_CR43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ccd.20722","volume":"68","author":"FM Kiblawi","year":"2006","unstructured":"Kiblawi FM, Sommer RJ, Levchuck SG. Transcatheter closure of patent foramen ovale in older adults. Catheter Cardiovasc Interv. 2006;68(1):136\u201342.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"525_CR44","first-page":"365","volume":"18","author":"J Alaeddini","year":"2006","unstructured":"Alaeddini J, Feghali G, Jenkins S, Ramee S, et al. Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale. J Invasive Cardiol. 2006;18(8):365\u20138.","journal-title":"J Invasive Cardiol"},{"key":"525_CR45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.107.709972","volume":"116","author":"TLP Slottow","year":"2007","unstructured":"Slottow TLP, Steinberg DH, Waksman R. Overview of the 2007 food and drug administration circulatory system devices panel meeting on patent foramen ovale closure devices. Circulation. 2007;116:677\u201382.","journal-title":"Circulation"},{"issue":"7","key":"525_CR46","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.WNL.0000119173.15878.F3","volume":"62","author":"SR Messe","year":"2004","unstructured":"Messe SR, Silverman IE, Kizer JR, Homma S, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2004;62(7):1042\u201350.","journal-title":"Neurology"},{"key":"525_CR47","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1161\/circ.113.10.e409","volume":"113","author":"RL Sacco","year":"2006","unstructured":"Sacco RL, Adams R, Albers G, Alberts MJ, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association\/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation. 2006;113:e409\u201349.","journal-title":"Circulation"},{"issue":"11","key":"525_CR48","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J, Mauri L, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med. 2012;366(11):991\u20139. This is a recently published randomized controlled trial to assess whether closure or medical therapy leads to less recurrence of ischemic strokes. Findings showed no significant improvement in rates of recurrence of stroke or TIA in cases with closure over medical therapy, even when degree of shunting was taken into account.","journal-title":"N Engl J Med"},{"issue":"12","key":"525_CR49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP, Khattab AA. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med. 2013;368(12):1083\u201391. This is a recently published randomized controlled trial to assess whether closure or medical therapy leads to less recurrence of ischemic events. Findings showed no significant improvement in rates of recurrence of stroke or TIA, as well as peripheral embolism, in cases with closure over medical therapy.","journal-title":"N Engl J Med"},{"issue":"12","key":"525_CR50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"J Carroll","year":"2013","unstructured":"Carroll J, Saver JL, Thaler DE, Smalling RW, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic strokes. N Engl J Med. 2013;368(12):1092\u2013100.","journal-title":"N Engl J Med"},{"issue":"1-2","key":"525_CR51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2013.11.027","volume":"337","author":"L Chen","year":"2014","unstructured":"Chen L, Luo S, Yan L, Zhao W. A systematic review of closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and cryptogenic stroke or transient ischemic attack. J Neurol Sci. 2014;337(1-2):3\u20137.","journal-title":"J Neurol Sci"},{"issue":"6","key":"525_CR52","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ccd.25122","volume":"82","author":"AM Pineda","year":"2013","unstructured":"Pineda AM, Nascimento FO, Yang SC, Kirtane AJ, et al. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Catheter Cardiovasc Interv. 2013;82(6):968\u201375.","journal-title":"Catheter Cardiovasc Interv"},{"key":"525_CR53","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","volume":"12","author":"AR Khan","year":"2013","unstructured":"Khan AR, Bin Abdulhak AA, Sheikh MA, Khan S, et al. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke. JACC Cardiovasc Interv. 2013;12:1316\u201323.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"525_CR54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.hlc.2007.11.141","volume":"18","author":"FA Ponnuthurai","year":"2009","unstructured":"Ponnuthurai FA, van Gaal WJ, Burchell A, Mitchell A, et al. Single centre experience with GORE-HELEX Septal Occluder for closure of PFO. Heart Lung Circ. 2009;18(2):140\u20132. This is an ongoing phase 3 clinical trial evaluating whether closure with the GORE HELEX Septal Occluder\/GORE Septal Occluder reduces incidence of recurrent stroke compared with medical therapy alone. The study is still ongoing; however, there is an improved effective closure rate with this device compared to previous trials.","journal-title":"Heart Lung Circ"},{"issue":"7","key":"525_CR55","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45(7):2160\u2013236. These are the revised 2014 American Heart Association\/American Stroke Association guidelines for secondary stroke prevention.","journal-title":"Stroke"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-015-0525-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11883-015-0525-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-015-0525-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T01:18:37Z","timestamp":1566868717000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11883-015-0525-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,17]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s11883-015-0525-6","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"value":"1523-3804","type":"print"},{"value":"1534-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,17]]},"article-number":"45"}}